Recombinant and Synthetic Vaccines

Recombinant and Synthetic Vaccines PDF Author: G. P. Talwar
Publisher: Springer
ISBN:
Category : Medical
Languages : en
Pages : 536

Get Book Here

Book Description
Vaccines have historically been the most cost effective agents for the prevention of human and animal diseases. This volume gives a state-of-the-art description of the recombinant and synthetic vaccines for animal use as well as for hepatitis, HIV, measles, etc. Extensively covered are Malaria and vaccines for the control of fertility. Also described are new recombinant vaccines for anti-tuberculosis immunity and hantavirus hemmorrhagic fever, the development of genetic toxoids for pertussis and cholera and new technologies enabling the delivery of multiple doses of vaccines at a single contact point. This volume with contributions by numerous experts will be a valuable addition in this rapidly developing field.

Recombinant and Synthetic Vaccines

Recombinant and Synthetic Vaccines PDF Author: G. P. Talwar
Publisher: Springer
ISBN:
Category : Medical
Languages : en
Pages : 536

Get Book Here

Book Description
Vaccines have historically been the most cost effective agents for the prevention of human and animal diseases. This volume gives a state-of-the-art description of the recombinant and synthetic vaccines for animal use as well as for hepatitis, HIV, measles, etc. Extensively covered are Malaria and vaccines for the control of fertility. Also described are new recombinant vaccines for anti-tuberculosis immunity and hantavirus hemmorrhagic fever, the development of genetic toxoids for pertussis and cholera and new technologies enabling the delivery of multiple doses of vaccines at a single contact point. This volume with contributions by numerous experts will be a valuable addition in this rapidly developing field.

Introduction to Recombinant Vaccines

Introduction to Recombinant Vaccines PDF Author: Dr. Ramesh C.K.
Publisher: Lulu.com
ISBN: 1365707342
Category : Education
Languages : en
Pages : 178

Get Book Here

Book Description
The immune system is a network of cells, tissues, and organs that work together to defend the body against attacks by "foreign" invaders. Invaders are primarily microbes such as bacteria, viruses, parasites and fungi. Because the human body provides an ideal environment for many microbes, they try to break in. It is the immune system's job to keep them out or, failing that, to seek out and destroy them. When the immune system hits the wrong target or is crippled, however, it can unleash seversl diseases, including allergy, arthritis or immune disorders.

Epitope Discovery and Synthetic Vaccine Design

Epitope Discovery and Synthetic Vaccine Design PDF Author: Clarisa Beatriz Palatnik-de-Sousa
Publisher: Frontiers Media SA
ISBN: 288945522X
Category : Antigens
Languages : en
Pages : 284

Get Book Here

Book Description
Since variolation, conventional approaches to vaccine development are based on live-attenuated, inactivated or purified pathogen-derived components. However, effective vaccines against global health threats such as HIV, parasite infections and tumors are difficult to achieve. On the other hand, synthetic vaccines based on immunogenic epitopes offer advantages over traditional vaccines since they are chemically defined antigens free from deleterious effects. Additionally, in contrast to live-attenuated vaccines, they do not revert to virulence in immunocompromised subjects, and different from genetic vaccines, they do not involve ethical questions. Traditional vaccines contain PAMPs and induce strong immune responses, while recombinant vaccines are less potent. In spite of the immunogenic weakness previously attributed to epitope-based vaccines a synthetic vaccine containing a 17 amino acid-epitope of the Pseudomonas aeruginosa Type IV pilus exceeded the protective potential of its cognate protein composed of 115 amino acids. Therefore, the efficacy yield of a synthetic vaccine can be potentiated by using the proper combination of target epitopes. Recent advances in adjuvant development, immunogen platforms for DNA vaccines and viral vectors also contributed to optimize immunogenicity. Another constraint to the use of epitope vaccines was their restriction to some MHC or HLA phenotypes. However, epitopes containing 20 or less amino acids of Plasmodium falciparum and Leishmania donovani bind to multiple HLA-DR and MHC receptors. Thus synthetic epitope vaccines may better meet the requirements of the regulatory agencies since they have lower costs and are easier to produce. The classical experimental approach for the development of an epitope-based vaccine involves the use of recombinant domains or overlapping 15-mer peptides spanning the full length of the target antigen, and the analysis of the induced antibody and/or T cell immune responses in vitro or in vivo. On the other hand, in silico tools can select peptides that are more likely to contain epitopes, reducing the number of sequence candidates. T cell epitope prediction dates back to 1980s, when the first algorithm was developed based on the identification of amphipathic helical regions on protein antigens. Since then, new methods based on MHC peptide-binding motifs or MHC-binding properties have been developed. The recent reverse vaccinology concept uses high-throughput genome sequencing and bioinformatics tools to identify potential targets of immune responses. The feasibility of this approach was shown for the first time in the design of a vaccine against Neisseria meningitides that is now in phase III clinical trials. In addition, different computational tools allow the determination of crucial gene(s) through comparative analyses between different pathogenic strains Alternatively, carbohydrates have been considered as key targets in developing safe and effective vaccines to combat cancer, bacterial and viral infections. Tumor associated carbohydrate antigens can be coupled covalently to protein carriers to target MHC receptors and improve immunogenicity and have reached already pre-clinical and clinical studies. In light of the recent availability of genomic tools, we believe that in the near future an increasing number of vaccine candidates, composed of defined epitopes, will be available for synthetic vaccines showing improved protection.

Recombinant Virus Vaccines

Recombinant Virus Vaccines PDF Author: Maureen C. Ferran
Publisher: Humana
ISBN: 9781493968671
Category : Medical
Languages : en
Pages : 0

Get Book Here

Book Description
This volume provides readers with methods and protocols for understanding the development of recombinant viruses and their use as vaccines platforms. Recombinant Virus Vaccines: Methods and Protocols details the use of recombinant vaccines that are employed to either produce immunogens in vitro or elicit antibody production in vivo. The chapters in this book are divided into four parts: Part I explores double-stranded DNA viruses; Part II discusses negative sense single-stranded RNA viruses; Part III talks about positive sense single-stranded RNA viruses; and Part IV describes bacteriophages. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Thorough and cutting-edge, Recombinant Virus Vaccines: Methods and Protocols is a valuable resource for scientists and clinicians who are interested in learning about and adopting methods for use in basic and biomedical research directed toward generating and developing recombinant viral vaccines.

Recombinant Poxviruses

Recombinant Poxviruses PDF Author: Matthew M. Binns
Publisher: CRC Press
ISBN: 9780849361791
Category : Science
Languages : en
Pages : 360

Get Book Here

Book Description
Recombinant Poxviruses provides a comprehensive examination of poxviruses with an emphasis on the potential of these viruses as new vaccines. The book considers a wide range of issues involved in producing new genetically engineered live vaccines, such as efficacy, safety, stability, cost, host range, immune response, immunization route, use of multivalent vaccines, and need for revaccination. The opening chapter describes the origin of vaccinia virus, its use to eradicate smallpox, and the pathogenesis of poxvirus infections. Subsequent chapters examine the molecular biology of poxviruses, methods of constructing vaccinia virus recombinants, and applications; the use and immune responses induced by poxvirus recombinants as live vaccines; and the important issues of the safety and immunogenicity of vaccinia virus. The book's final two chapters report the progress that has been made developing avipoxviruses and parapoxviruses as candidate recombinant vaccines. Recombinant Poxviruses will be a welcome addition to the bookshelves of virologists, microbiologists, infectious disease specialists, and veterinarians.

Recombinant DNA Vaccines

Recombinant DNA Vaccines PDF Author: Richard Isaacson
Publisher: CRC Press
ISBN: 9780824786991
Category : Medical
Languages : en
Pages : 432

Get Book Here

Book Description


Novel Strategies in the Design and Production of Vaccines

Novel Strategies in the Design and Production of Vaccines PDF Author: Sara Cohen
Publisher: Springer Science & Business Media
ISBN: 1489913823
Category : Medical
Languages : en
Pages : 197

Get Book Here

Book Description
Vaccination is one of the most efficient and cost effective methods of promoting human health and has been in clinical use for at least 200 years. Nevertheless, infectious diseases continue to constitute a constant threat to the well being of humanity. Common pathogens, once believed to be under control, acquire increased virulence and resistance to drugs, while exotic microorganisms emerged from hidden reservoirs to cause yet incurable diseases in humans. These changes, together with epidemic outbreaks related to political and socio-economic instabilities, increase the needs for the development of new, advanced vaccines. In this volume, devoted to the proceedings of the 39th OHOLO Conference, we present some of the recent strategies for the design and production of novel vaccines. The advent of recombinant DNA technology has stimulated the production of several subunit vaccines. In spite of the obvious advantages to this approach, the limited immuno genicity of many subunit candidates has hindered their development. Strategies to enhance the immunogenicity of subunit vaccines is therefore critical. Several approaches toward this goal, including design of novel adjuvants and delivery systems as well as design of advantageous carriers, are presented here. Among the carriers evaluated here are polypep tides (flagellin, HBV core antigen, J3-galactosidase), attenuated virions (Vaccinia, Sindbis), and nonpathogenic licensed bacteria (Salmonella).

Mucosal Vaccines

Mucosal Vaccines PDF Author: Hiroshi Kiyono
Publisher: Elsevier
ISBN: 0080537057
Category : Medical
Languages : en
Pages : 501

Get Book Here

Book Description
This comprehensive, authoritative treatise covers all aspects of mucosal vaccines including their development, mechanisms of action, molecular/cellular aspects, and practical applications. The contributing authors and editors of this one-of-a-kind book are very well known in their respective fields. Mucosal Vaccines is organized in a unique format in which basic, clinical, and practical aspects of the mucosal immune system for vaccine development are described and discussed. This project is endorsed by the Society for Mucosal Immunology. Provides the latest views on mucosal vaccines Applies basic principles to the development of new vaccines Links basic, clinical, and practical aspects of mucosal vaccines to different infectious diseases Unique and user-friendly organization

Recombinant and Synthetic Cancer Vaccines

Recombinant and Synthetic Cancer Vaccines PDF Author: Willem Willie Overwijk
Publisher:
ISBN:
Category :
Languages : en
Pages : 288

Get Book Here

Book Description


Pharmaceutical Biotechnology

Pharmaceutical Biotechnology PDF Author: Daan J. A. Crommelin
Publisher: CRC Press
ISBN: 9780415285018
Category : Medical
Languages : en
Pages : 456

Get Book Here

Book Description
The field of pharmaceutical biotechnology is evolving rapidly. A whole new arsenal of protein pharmaceuticals is being produced by recombinant techniques for cancer, viral infections, cardiovascular and hereditary disorders, and other diseases. In addition, scientists are confronted with new technologies such as polymerase chain reactions, combinatorial chemistry and gene therapy. This introductory textbook provides extensive coverage of both the basic science and the applications of biotechnology-produced pharmaceuticals, with special emphasis on their clinical use. Pharmaceutical Biotechnology serves as a complete one-stop source for undergraduate pharmacists, and it is valuable for researchers and professionals in the pharmaceutical industry as well.